Aortoiliac occlusive disease
(Redirected from Leriche's syndrome)
Aortoiliac occlusive disease (AIOD) is a medical condition characterized by the blockage of the aorta and/or the iliac arteries, which are the main blood vessels that supply blood to the lower half of the body. This blockage is typically caused by atherosclerosis, a condition where fatty deposits build up in the arteries, narrowing them and reducing blood flow.
Causes[edit | edit source]
The primary cause of aortoiliac occlusive disease is atherosclerosis. Other factors that can contribute to the development of AIOD include smoking, diabetes, hypertension, and high levels of cholesterol in the blood.
Symptoms[edit | edit source]
The symptoms of aortoiliac occlusive disease can vary depending on the severity of the blockage. Common symptoms include pain in the legs or buttocks while walking (known as claudication), numbness or weakness in the legs, and erectile dysfunction in men. In severe cases, AIOD can lead to critical limb ischemia, a serious condition characterized by chronic pain, skin ulcers, and gangrene.
Diagnosis[edit | edit source]
Diagnosis of aortoiliac occlusive disease typically involves a physical examination, during which a doctor may listen for abnormal sounds in the arteries using a stethoscope. Additional diagnostic tests may include angiography, ultrasound, and computed tomography (CT) scans.
Treatment[edit | edit source]
Treatment for aortoiliac occlusive disease aims to improve blood flow to the affected areas. This can be achieved through lifestyle changes, medication, or surgery. Lifestyle changes may include quitting smoking, exercising regularly, and maintaining a healthy diet. Medications used to treat AIOD include statins, antiplatelet drugs, and antihypertensive drugs. In severe cases, surgical procedures such as angioplasty or bypass surgery may be necessary.
Prognosis[edit | edit source]
With appropriate treatment, the prognosis for individuals with aortoiliac occlusive disease is generally good. However, it is important for individuals with AIOD to manage their risk factors and adhere to their treatment plan to prevent the disease from progressing.
See also[edit | edit source]
This vascular disease related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
